Loading
NT
Neuphoria Therapeutics Inc. Stock: price and insider trades · United States
US·Mcap US$17.9M
No insider purchase over the last 90 days. The latest, by Lynx1 Capital Management LP, was filed 23 Oct 2025.
Neuphoria Therapeutics Inc.: what insiders have been doing
Neuphoria Therapeutics Inc. has a thin disclosure history in our data (latest filing: 23 October 2025). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€3M
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleLynx1 Capital Management LP1 buy
Since the insiders bought
- -47.0%Entry US$6.24 · Close 19 Oct 2026 US$3.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
US$3.31
Analyst consensus
Income statement
RevenueUS$1.2M
EBITDA-US$8.3M-711% margin
Net income-US$13.5M-1145.7% margin
Valuation
PER (forward)-1.3x
P/Book0.7x
Balance sheet & cash
Market capUS$17.9M
Total debtUS$34.3k
Free Cash Flow-US$12.4M
Debt / Equity0%
Profitability & ownership
ROE-61.7%
ROA-19.7%
% insiders5.0%
% institutions42.8%
Last declaration on 23 October 2025
Declarations1 total
639,110 shares@ US$5.137100.0% of flowCommon stock, $0.00001 par value per shareSEC:0000902664-25-004536:0
Canonical exit: 19 Jan 2026 (T+90)
1 of 1 declaration
About Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc. is a company focused on developing innovative treatments for neurological disorders. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
